Mode
Text Size
Log in / Sign up
N/A N=26 Randomized Single-blind Supportive Care

Effectiveness of Telerehabilitation in High Risk of Infants

Early Intervention

Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcome: Primary: Bayley III - Cognitive — 77.69; 78.46 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Telerehabilitation (Other); Home-based (Other)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Saglik Bilimleri Universitesi
Primary completion
Feb 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Bayley III - Cognitive
77.69; 78.46
PRIMARY
Bayley III - Cognitive Value at Day 30
82.08; 77.08
PRIMARY
Bayley III - Cognitive Value at Day 60
84.58; 73.33
PRIMARY
Bayley III - Cognitive Value at Day 90
89.17; 82.08
PRIMARY
Bayley III - Language
77.85; 83.38
PRIMARY
Bayley III - Language Value at Day 30
85.17; 85.42
PRIMARY
Bayley III - Language Value at Day 60
84.83; 82.75
PRIMARY
Bayley III - Language Value at Day 90
89.92; 87.00
PRIMARY
Bayley III - Motor
81.08; 88.54
PRIMARY
Bayley III - Motor Value at Day 30
92.33; 88.08
PRIMARY
Bayley III - Motor Value at Day 60
89.00; 81.50
PRIMARY
Bayley III - Motor Value at Day 90
101.33; 95.08
PRIMARY
Hammersmith Infant Neurological Examination (HINE)
51.92; 50.15
PRIMARY
HINE Value at Day 30
58.08; 55.50
PRIMARY
HINE Value at Day 60
66.50; 61.92
PRIMARY
HINE Value at Day 90
74.00; 68.92
PRIMARY
Goal Attainment Scale (GAS)
-1.62; -0.85
PRIMARY
GAS Value at Day 30
-0.42; -1.25
PRIMARY
GAS Value at Day 60
-0.33; -1.25
PRIMARY
GAS Value at Day 90
0.50; -0.50

Summary

While the mortality rate in preterm births has decreased thanks to recent developments in the field of medicine, disability risk factors increase for premature babies. Premature birth, low birth weight, and all accompanying problems in this process reveal the concept of the risky baby. Early intervention is very important for these babies who are at risk for neurodevelopmental problems. Although early intervention is a general concept, the subject the investigators focus on is early physiotherapy approaches. Early physiotherapy approaches include many methods. However, recently, family-centered approaches have been emphasized and studies have been carried out on this issue; Likewise, the goal-oriented therapy approach, which is a treatment with a high level of evidence, is also being investigated. Telerehabilitation, on the other hand, has become a method that is frequently used with the increase in the use of technological methods. The effectiveness of family-centered, goal-oriented physiotherapy approaches is known in previous studies on this subject; There are studies conducted on a remotely monitored portable intelligent system created for telerehabilitation, but no studies have been found in which telerehabilitation has been applied using the real-time video conferencing method.

Eligibility Criteria

Inclusion Criteria

  • Babies born before <37 weeks of gestation and treated in the neonatal intensive care unit
  • Infants with neurologic abnormalities (muscle hypertonia, hypotonia, hyperarousal, and abnormal general movements or cranial ultrasound abnormalities) at moderate to high risk of cerebral palsy
  • Babies referred to physiotherapy due to motor developmental delay and neurological dysfunction
  • Babies whose age range is between 0-12 months (corrected age will be calculated for premature babies)
  • Being diagnosed as a neurologically and developmentally risky baby
  • Babies who have completed their medical treatment and are not in neonatal intensive care
  • Babies of families who agreed to participate in the study and approved the informed consent form.

Exclusion Criteria

  • Babies with congenital cyanotic heart problems or cystic fibrosis
  • Babies with genetic disease or congenital anomaly
  • Infants on ventilator
  • Babies of families who do not accept to work
  • Babies of families who cannot come to the control
  • Families that cannot be contacted every week
  • Babies going to a special education and rehabilitation center
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05333224). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search